← Back to Search

Lubricant

Walgreen's Lubricant Balance for Dry Eye Syndrome

Phase 4

Recruiting

Led By Jay Mashouf, OD

Research Sponsored by Scripps Poway Eyecare and Optometry

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Subjects between the ages of 18-65

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 weeks

Awards & highlights

Study Summary

This trial is studying the effects of two different eye drops on dry eye symptoms and damage to the cornea and conjunctiva. It is a controlled study where participants will be randomly assigned to one of

Who is the study for?

This trial is for individuals with Dry Eye Syndrome. Participants will be assessed at the start and during two follow-up visits. The study excludes anyone who doesn't meet the specific requirements set by the researchers, which are not detailed here.Check my eligibility

What is being tested?

The study compares Systane Complete Multi-Dose PF and Walgreen's Lubricant Balance eye drops to see which is better for dry eyes. It's a controlled test where patients don't know which treatment they're getting, and they're randomly assigned to one of two groups.See study design

What are the potential side effects?

While specific side effects aren't listed, eye drops can sometimes cause temporary vision blurring, eye discomfort or irritation, redness, itching, or watery eyes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

SANDE Questionnaire

Other outcome measures

Corneal and conjunctival staining

Non-invasive tear breakup time

Trial Design

2Treatment groups

Experimental Treatment

Group I: Walgreen's Lubricant BalanceExperimental Treatment1 Intervention

Group II: Systane Complete Multi-Dose PFExperimental Treatment1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

SengiIndustry Sponsor

19 Previous Clinical Trials

1,563 Total Patients Enrolled

Scripps Poway Eyecare and OptometryLead Sponsor

1 Previous Clinical Trials

42 Total Patients Enrolled

Jay Mashouf, ODPrincipal InvestigatorScripps Poway Eyecare & Optometry

1 Previous Clinical Trials

42 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment for this medical study currently open?

"As per clinicaltrials.gov, the current status of this study does not involve active participant recruitment. The trial was originally posted on February 1st, 2024 and last updated on January 12th, 2024. However, it is worth noting that there are currently 72 other ongoing clinical trials actively seeking participants at this time."

Answered by AI

Is it possible for me to enroll in this clinical trial?

"In order to meet the eligibility criteria for this clinical trial, individuals must have a diagnosis of dry eye syndrome and fall within the age range of 18 to 65 years. The study aims to enroll approximately 70 participants."

Answered by AI

What is the level of patient safety associated with Systane Complete Multi-Dose PF?

"Given that this trial falls under Phase 4, signifying the approval of Systane Complete Multi-Dose PF as a treatment, our team at Power rates its safety with a score of 3."

Answered by AI